This week sees a number of junior gold explorers inch closer towards their public debut, with low Enterprise Value (EV) names like Askari Metals (ASX: AS2) and Monger Gold (ASX: MMG) among those likely to see high trading interest. The biggest listing of the week will be between Lumos Diagnostics (ASX: LDX), a health care stock seeking FDA approval for its finger prick blood test, and integrated logistics business Silk Logistics (ASX: SLH), which spruiks its port-to-door' service offering. 

New listing activity in the US is likely to be subdued after last week proved to be the biggest week for the US ipo market since 2004.

Upcoming ipos

MarketCompanyFocusipo sizeExpected debutASXLumos Diagnostics (LDX)Manufacturer and distributor of point-of-care diagnostic tests and readers$63mJuly 5ASXOZZ Resources (OZZ)Gold and base metals explorer$5mJuly 5ASXButn (BTN)End-to-end transaction financing solution provider$20mJuly 6ASXMonger Gold (MMG)Gold minerals explorer$6mJuly 6ASXResource Base (RBX)Copper and gold explorer$5.5mJuly 6ASXAskari Metals (AS2)Copper and gold explorer$6mJuly 7ASXBurley Minerals (BUR)Iron ore and base metals explorer$6mJuly 7ASXCharger Metals (CHR)Lithium and base metals explorer$6mJuly 8ASXLocksley Resources (LKY)Copper and gold explorer$5mJuly 8ASXMt Monger Resources (MTM)Gold minerals explorer$5mJuly 8ASXPacgold (PGO)Gold minerals explorer$6mJuly 8ASXDRA Global (DRA)Diversified engineering, project delivery and operations management group$20mJuly 9ASXSilk Logistics (SLH)Integrated logistics provider$70mJuly 9ASXGold 50 (G50)Gold explorer$10mTBCUSMinim (MINM)Intelligent networking products providerUS$29mTBCUSLinkDoc Technology (LDOC)AI healthcare data companyUS$200mJuly 9USUnicycive Therapeutics (UNCY)Biotech firm focused on kidney diseaseUS$31.4mTBC

*All dates are subject to change and should be treated as an indicative guide only

Future ASX Listings

With the number of software-as-a-service stocks on the ASX continuing to surge, Brisbane-based Genie Solutions has embarked on plans to join the chorus later this year. A software developer for more than 21,000 medical practices across the country, the business is eyeing a fresh round of capital after more than 25 years. Now generating approximately $30 million in revenue per year, the company relies on recurring revenue to bolster its books.Life insurer NobleOak upsized its ipo last week, increasing the proceeds from $48 million to around $63 million. At a price of $1.95 per share, the company is set to be valued at about $160 million, representing around 18-times the FY22 forecast for underlying profit.The geospatial mapping segment already includes names like Nearmap (ASX: NEA), Pointerra (ASX: 3DP) and Aerometrex (ASX: AMX), and now Euclideon is understood to be looking to join the party. Media reports suggest the 3D data management business will target an ASX listing towards the end of the year, with $15 million in capital expected to be sought to service its book of clients across the mining and defence industries, among others.Premium oyster producer East33 is making its second attempt at an ASX listing. Eyeing $32 million at $0.20 per share, the business is targeting a valuation of around $55.3 million. It counts Regal Funds Management among its existing holders, and currently produces 15.1 million oysters per annum, with hopes to ramp this up to 19 million.Another name making a second effort to list is Best & Less, this time with $40 million in support from retail billionaire Brett Blundy, who has previously invested in Adairs (ASX: ADH), Dusk (ASX: DSK) and Lovisa (ASX: LOV). The offer will target $60 million at $2.16 per share, providing a valuation of circa 7-times pro-forma earnings per share for CY21. The stock is scheduled to list on July 26.Another name putting the finishing touches on its upcoming listing is Israeli insurance marketing technology business Gefen. Formed in 2014, the firm's technology facilitates and streamlines communications between insurance companies. Gefen is looking to debut with a market cap of $127 million, with names on its register including L1 Capital, Regal Funds Management, Ellerston Capital and Perennial Value Management.On the contrary, plans to list lending business Grow Finance came to a halt over recent days. Having been active in the market to complete a $44 million offer, the business shelved its ipo in light of subdued demand from investors.And finally, not long after being caught up in acquisition news, Vocus' New Zealand division is a candidate to be spun-off. That comes amid talk of an expected valuation in the vicinity of $500 million.

Future US Listings

Overseas, amid the US ipo market's busiest week since 2004, a host of other companies unveiled plans regarding their listing ambitions. Discount broker Robinhood Markets (HOOD) was the highest-profile name among the bunch, although the company has yet to provide a target value or timeline for its public debut. It is understood the business, with US$80 billion in share holdings across its platform, will seek to raise US$100 million, also unveiling its first profit in 2020.While Robinhood stole some of the thunder last week, global vehicle battery manufacturer Clarios International (BTRY) was the largest candidate to file for an ipo. Although the company has outlined plans to raise up to US$100 million, sources suggest the final raise may be closer to US$2 billion, for an enterprise value greater than US$20 billion on listing.Global asset manager TPG has raised the notion of an initial public offer, while also keeping the door open to a transaction with a Special Purpose Acquisition Company (SPAC). TPG has looked into plans for a liquidity event over recent years, albeit without committing to going public at any point. Should the business decide to list, some estimates put its value at around US$10 billion.

With nearly 30 other businesses pitching their ipo aspirations to the market last week, some of the names included:

• Fruit and vegetable company Dole (DOLE), eyeing a US$600 million ipo;

• Digital language learning platform Duolingo (DUOL), targeting a US$250 million ipo

• Content marketing platform Outbrain (OB), seeking US$100 million

Be sure to keep an eye out for our end-of-week bulletin covering all the major results among new ASX and US ipos.